Skip to main content
Figure 6 | Journal of Hematology & Oncology

Figure 6

From: A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome

Figure 6

Cardiotoxicity (CT) rate of CAG regimen in AML and MDS patients--Forest plot of CT event rates. Summary CT rates of CAG regimen were calculated using the random-effects model. Horizontal lines through the squares represent 95% CIs. The diamonds represent the overall CT event rate from the meta-analyses and the corresponding 95% CIs.

Back to article page